NCT06270082 2025-09-19Study of IK-595 in RAS- or RAF-altered Advanced TumorsIkena OncologyPhase 1 Terminated75 enrolled
NCT05500508 2024-12-24Oral AMXT 1501 Dicaprate in Combination With IV DFMOAminex Therapeutics, Inc.Phase 1/2 Terminated15 enrolled